Dean J. Naylor
Corporate Officer/Principal presso The University of Queensland
Posizioni attive di Dean J. Naylor
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| The University of Queensland | Corporate Officer/Principal | - | - |
Storia della carriera di Dean J. Naylor
Precedenti posizioni note di Dean J. Naylor
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Adelaide | Corporate Officer/Principal | - | - |
CBio Ltd.
 CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Australia | 4 |
Posizioni
| Corporate Officer/Principal | 3 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
CBio Ltd.
CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Health Technology |
- Borsa valori
- Insiders
- Dean J. Naylor
- Esperienza
